0000899243-22-037965.txt : 20221207 0000899243-22-037965.hdr.sgml : 20221207 20221207212603 ACCESSION NUMBER: 0000899243-22-037965 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221206 FILED AS OF DATE: 20221207 DATE AS OF CHANGE: 20221207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAAB THOMAS R II CENTRAL INDEX KEY: 0001230708 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39473 FILM NUMBER: 221451311 MAIL ADDRESS: STREET 1: C/O INSPIRE PHARMACEUTICALS, INC. STREET 2: 4222 EMPEROR BLVD., SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LENSAR, Inc. CENTRAL INDEX KEY: 0001320350 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 320125724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2800 DISCOVERY DRIVE STREET 2: SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32826 BUSINESS PHONE: 888-536-7271 MAIL ADDRESS: STREET 1: 2800 DISCOVERY DRIVE STREET 2: SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32826 FORMER COMPANY: FORMER CONFORMED NAME: LensAR Inc DATE OF NAME CHANGE: 20070703 FORMER COMPANY: FORMER CONFORMED NAME: LaserSoft Vision Inc DATE OF NAME CHANGE: 20050310 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-06 0 0001320350 LENSAR, Inc. LNSR 0001230708 STAAB THOMAS R II C/O LENSAR, INC. 2800 DISCOVERY DRIVE ORLANDO FL 32826 0 1 0 0 Chief Financial Officer Common Stock 2022-12-06 4 P 0 2025 3.162 A 134404 D Common Stock 2022-12-07 4 P 0 727 3.156 A 135131 D The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.15 to $3.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Includes (i) 970 shares acquired under the Issuer's Employee Stock Purchase Plan since January 13, 2022, the date of the last Form 4 filed by the Reporting Person (the "Reference Date"), and (ii) 19,276 shares that were previously awarded as restricted stock on July 22, 2020 (subject to an amendment of such award on December 7, 2020) and that vested between the Reference Date and the date hereof. Such restricted stock award was reported in the Reporting Person's Form 3 filed on September 17, 2020, and additional restricted stock awarded pursuant to the related amendment was reported in the Reporting Person's Form 4 filed on December 10, 2020. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.15 to $3.17. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. /s/ Thomas R. Staab, II 2022-12-07